Telehealth geriatric assessment significantly improves short-term outcomes for older adults with advanced cancers … JAMA releases feeding guide for advanced dementia patients and families … Heart ...

A support group for people with Alzheimer’s, their families and caregivers is inviting the public to join them for a walk ...

The National Institute for Health and Care Excellence is standing by its earlier decision to turn down donanemab and ...

Two drugs – donanemab and lecanemab – have been rejected for NHS use because their benefits are "too small" to justify their ...

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge ...

The National Institute for Health and Care Excellence (NICE) has today issued final decisions on lecanemab and donanemab, ...

Higher levels of wellbeing may help reduce the risk of memory loss in middle age, suggests new research, which tracked more than 10,000 over ...

THE NHS is failing to keep up with science, experts blasted after breakthrough new dementia drugs were rejected again by the ...

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s ...

While social isolation has long been known a risk factor for Alzheimer’s disease, a new study showed that being more sociable ...